| Jennifer R Gatchel, MD, PHD | |
|
115 Mill St, Belmont, MA 02478-1064 | |
| (617) 855-3036 | |
| Not Available |
| Full Name | Jennifer R Gatchel |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 15 Years |
| Location | 115 Mill St, Belmont, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053632398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 257787 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Mclean Hospital Corporation | 9436040961 | 139 |
News Archive
Former football star Beau Orth, known to many Las Vegans as "Orth," is set to take the stand Friday in the multimillion dollar malpractice trial over a surgery he claims ended his playing career and caused lifelong injuries.
NPR reports on how efforts to set uniform standards for electronic claims for health care services could pay off.
Using a specially designed robotic microscope to study cultured cells, researchers have found evidence that abnormal protein clumps called inclusion bodies in neurons from people with Huntington's disease (HD) prevent cell death.
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 4 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Former football star Beau Orth, known to many Las Vegans as "Orth," is set to take the stand Friday in the multimillion dollar malpractice trial over a surgery he claims ended his playing career and caused lifelong injuries.
NPR reports on how efforts to set uniform standards for electronic claims for health care services could pay off.
Using a specially designed robotic microscope to study cultured cells, researchers have found evidence that abnormal protein clumps called inclusion bodies in neurons from people with Huntington's disease (HD) prevent cell death.
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 4 days ago
| Entity Name | The Mclean Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114979580 PECOS PAC ID: 9436040961 Enrollment ID: O20040323001228 |
News Archive
Former football star Beau Orth, known to many Las Vegans as "Orth," is set to take the stand Friday in the multimillion dollar malpractice trial over a surgery he claims ended his playing career and caused lifelong injuries.
NPR reports on how efforts to set uniform standards for electronic claims for health care services could pay off.
Using a specially designed robotic microscope to study cultured cells, researchers have found evidence that abnormal protein clumps called inclusion bodies in neurons from people with Huntington's disease (HD) prevent cell death.
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 4 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Former football star Beau Orth, known to many Las Vegans as "Orth," is set to take the stand Friday in the multimillion dollar malpractice trial over a surgery he claims ended his playing career and caused lifelong injuries.
NPR reports on how efforts to set uniform standards for electronic claims for health care services could pay off.
Using a specially designed robotic microscope to study cultured cells, researchers have found evidence that abnormal protein clumps called inclusion bodies in neurons from people with Huntington's disease (HD) prevent cell death.
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer R Gatchel, MD, PHD 115 Mill St, Belmont, MA 02478-1064 Ph: (617) 855-3036 | Jennifer R Gatchel, MD, PHD 115 Mill St, Belmont, MA 02478-1064 Ph: (617) 855-3036 |
News Archive
Former football star Beau Orth, known to many Las Vegans as "Orth," is set to take the stand Friday in the multimillion dollar malpractice trial over a surgery he claims ended his playing career and caused lifelong injuries.
NPR reports on how efforts to set uniform standards for electronic claims for health care services could pay off.
Using a specially designed robotic microscope to study cultured cells, researchers have found evidence that abnormal protein clumps called inclusion bodies in neurons from people with Huntington's disease (HD) prevent cell death.
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 4 days ago
Evan D Murray, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 115 Mill St, Mclean Hospital, Belmont, MA 02478 Phone: 617-855-2354 Fax: 617-855-3731 | |
Stephane Poulin, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Mclean Hospital, 115 Mill Street, Belmont, MA 02478 Phone: 617-855-2183 | |
Dr. Emily J Deringer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3621 | |
Dr. Marni Joy Chanoff, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3937 | |
Prof. Bruce Michael Cohen, M.D., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3227 Fax: 617-855-3670 | |
John D Gambill, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 29 Stults Rd, Belmont, MA 02478 Phone: 617-489-2645 | |
Ashley Beaulieu, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3117 |